Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
18.74
+0.26 (1.41%)
Aug 18, 2026, 10:11 AM EDT - Market open

Trevi Therapeutics Analyst Ratings

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
JonesTrading
JonesTrading
Buy
Reiterates
$24$28
BuyReiterates$24$28+49.41%Aug 13, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Maintains
$24
BuyMaintains$24+28.07%Aug 11, 2026
Morgan Stanley
Morgan Stanley
Buy
Reiterates
$23
BuyReiterates$23+22.73%Aug 10, 2026
Needham
Needham
Buy
Maintains
$23
BuyMaintains$23+22.73%Aug 7, 2026
Raymond James
Raymond James
Buy
Maintains
$40
BuyMaintains$40+113.45%Aug 7, 2026
B. Riley Securities
B. Riley Securities
Buy
Initiates
$31
BuyInitiates$31+65.42%Aug 7, 2026
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$25$30
BuyReiterates$25$30+60.09%Aug 7, 2026
Oppenheimer
Oppenheimer
Buy
Reiterates
$24$25
BuyReiterates$24$25+33.40%Aug 7, 2026

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

  • Investment ideas from the top Wall Street analysts
  • Unlimited access to all data and tools
  • Advanced analyst filtering and sorting options
  • Up to 3 years of analyst rating history
Sign Up Today

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate
The percentage of ratings that are profitable.
Average Return
The average percentage return within one year of the rating.
Rating Count
The more ratings the analyst has provided, the higher the score.
Recency
Ratings provided within the past year contribute to a higher score.